Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (1863)	8/9/2007 11:17:19 AM
From: Jibacoa	Respond to of 3722

MYGN Has been up for 6 days on a roll.<g> bigcharts.marketwatch.com If it continues its present momentum, it seems it will be able to test its February 2002 H at 48.40 before it could retest support at the $40 level, as you mentioned. bigcharts.marketwatch.com It has had 4Qs of double digit improvement on revenues & was able to cut its loss significantly in the last Q.The EL for 2007 is around $0.85 vs. the $1.05 in 2006 although for 2008 they aren't expecting significant further cut on its losses.<g> However, the results of Flurizan on Alzheimer's are expected to be ready in the first half of 2008 or positive results on its announced collaboration with AZN's KuDOS on the PIIs of MYGN's AZD2281 for patients with BRCA1 or BRCA2 breast or ovarian Cas. may greatly change the expected results, not counting MYGN's several other irons on the fire.<g> With some good news, it seems MYGN could easily retest the $60 level.<g> bigcharts.marketwatch.com Bernard